Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 2/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.65 |
| ▸ | SHBG | P04278 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.65 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.65 |
| ▸ | AR | P10275 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | MGAM | O43451 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891363 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL1114187 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL15369324 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL12394882 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL868473 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL16305624 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL12377165 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL15426613 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL22844489 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 | |
| SCHEMBL1331733 | 1.00 | CYP19A1 (1.00) | CYP19A1AKR1B10AKR1B1OR51E2GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140124-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2026-05-21 | — | — | US | claimed |
| EP-4605743-A1 | PCOS STRATIFICATION | The University of Birmingham (GB) | 2025-08-27 | — | — | EP | claimed |
| WO-2024084250-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2024-04-25 | — | — | WO | claimed |
| US-8623849-B2 | Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin | Shelar, Ashok Ranganath (IN) | 2014-01-07 | — | — | US | claimed |
| EP-2279195-B1 | MEDICINAL APPLICATIONS OF BENZOIC ACID HYDRAZONES SYNTHESIZED ON THE BASIS OF STEROIDAL TIGOGENIN | SHELAR ASHOK RANGANATH (IN) | 2013-05-15 | — | — | EP | claimed |
| EP-2279195-A1 | MEDICINAL APPLICATIONS OF BENZOIC ACID HYDRAZONES SYNTHESIZED ON THE BASIS OF STEROIDAL TIGOGENIN | Shelar, Ashok Ranganath (IN) | 2011-02-02 | — | — | EP | claimed |
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | PETRONI ANNA | 2010-12-16 | — | — | US | claimed |
| EP-1962856-B1 | MEDICAMENT BASED ON A MONOESTER OF STEROIDS WITH LONG CHAIN FATTY ACIDS | PETRONI ANNA (IT) | 2010-10-20 | — | — | EP | claimed |
| WO-2009144738-A1 | MEDICINAL APPLICATIONS OF BENZOIC ACID HYDRAZONES SYNTHESIZED ON THE BASIS OF STEROIDAL TIGOGENIN | SHELAR ASHOK RANGANATH (IN) | 2009-12-03 | — | — | WO | claimed |
| EP-1807062-A4 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | ENDORECH INC (CA) | 2009-06-03 | — | — | EP | claimed |
| EP-1807062-A1 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | Endorecherche Inc. (CA) | 2007-07-18 | — | — | EP | claimed |
| US-20060178352-A1 | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | ENDORECHERCHE, INC. | 2006-08-10 | — | — | US | claimed |
| WO-2006047859-A1 | USE OF ANDROGENS TO REDUCE THE LIKELIHOOD OF ACQUIRING OR TO TREAT SKIN AGING | ENDORECHERCHE, INC. (CA) | 2006-05-11 | — | — | WO | claimed |
| US-20020165195-A1 | Method of treating androgen-dependent disorders | SCHERING CORPORATION | 2002-11-07 | — | — | US | claimed |
| EP-1102582-A2 | INHIBITORS OF TYPE 3 3ALPHA-HYDROXYSTEROID DEHYDROGENASE | Endorecherche Inc. (CA) | 2001-05-30 | — | — | EP | claimed |
| WO-2000007576-A2 | INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE | ENDORECHERCHE, INC. (CA) | 2000-02-17 | — | — | WO | claimed |
| US-20260140124-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2026-05-21 | — | — | US | disclosed |
| EP-4712980-A1 | TREATMENT OF BREAST TISSUE | Havah Therapeutics Pty Ltd (AU) | 2026-03-25 | — | — | EP | disclosed |
| US-4102884-A | TREATING A 3,14-DIHYDROXY-CARDENOLIDE WITH OXYGEN AND N-BROMOACETAMIDE IN THE PRESENCE OF PLATINUM, THEN WITH ETHANEDITHIOL, RANEY NICKEL | STEELE CHEMICALS CO. LTD. (CA) | 1978-07-25 | — | — | US | disclosed |
| US-4013688-A | STEROIDS | THE UPJOHN COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | ACAT1, ACAT2, HSD17B12 | CYP19A1 99/4885AKR1B10 202/4885AKR1B1 152/4885 |
| US-20260140124-A1 | PCOS STRATIFICATION | HSD17B3, AKR1C3, HSD17B11 | CYP19A1 21/4885AKR1B10 20/4885AKR1B1 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.